Rhenman & Partners Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-40,000
Closed -$371K 103
2017
Q2
$371K Hold
40,000
0.05% 95
2017
Q1
$371K Hold
40,000
0.06% 93
2016
Q4
$335K Hold
40,000
0.06% 93
2016
Q3
$275K Hold
40,000
0.04% 96
2016
Q2
$198K Hold
40,000
0.04% 95
2016
Q1
$386K Buy
+40,000
New +$386K 0.08% 90